Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2005 Abstract: Is Roux-en-Y Gastric Bypass Surgery the Most Effective Treatment for Type 2 Diabetes Mellitus in Morbidly Obese Patients?
Back to 2005 Program
Is Roux-en-Y Gastric Bypass Surgery the Most Effective Treatment for Type 2 Diabetes Mellitus in Morbidly Obese Patients?
Alfonso Torquati, Vanderbilt University Medical Center - Department of Surgery, Nashville, TN; Rami Lutfi, Vanderbilt University Medical Center, Nashville, TN; Naji Abumrad, Vanderbilt University Medical Center Dept. of Surgery, Nashville, TN; William O. Richards, Vanderbilt University Dept. of Surgery, Nashville, TN

Type 2 diabetes mellitus (T2DM) is an established risk factor for cardiovascular diseases. The rising prevalence of obesity is increasing the burden of this disease and consequently of cardiovascular mortality. In retrospective series, improvement in glycemic control in obese patients with T2DM has been related to weight loss after bariatric surgery. Prospective data regarding resolution of T2DM after gastric bypass surgery (GBS) have been scant. Therefore, the aim of our study was to analyze the efficacy of the GBS in reversing T2DM in a prospective cohort of morbidly obese patients.

Morbidly obese patients with T2DM undergoing laparoscopic GBS were enrolled in the study. Diagnosis of T2DM was made according to WHO criteria. Patients underwent assessment of fasting glucose, glycosylated hemoglobin (HbA1C), lipid profile, and waist circumference measurements at baseline and 6-month after surgery. Logistic regression was used in both univariate and multivariate modeling to identify independent variables associated with complete resolution of T2DM. Complete resolution of T2DM was defined by normal levels of fasting plasma glucose and HbA1C after discontinuing medical treatment.

The study enrolled 50 consecutive patients. Six months after surgery, fasting plasma glucose decreased from a preoperative mean of 16150 mg/dL to 10833 mg/dL (P=0.001) and HbA1C decreased from a preoperative mean of 7.5 1.6 % to 6.2 1.2 (P=0.001). Resolution of T2DM was achieved in 35 (70%) patients (full response). The remaining 15 patients decreased the daily medication requirements (partial response). On univariate analysis, preoperative variables associated with resolution of T2DM were: waist circumference <127 cm inches (P<0.001), and absence of insulin treatment. Waist circumference and treatment without insulin remained significant predictors of T2DM resolution after GBS in the multivariate logistic regression model after adjusting for covariates. Waist circumference <127 cm increased 40 times the chance to have T2DM resolution after GBS (OR 40.4; 95% CI 4.6-352; P=0.001). Absence of insulin treatment increased 9 times the chance to have resolution of the T2DM after GBS (OR 9; 95% CI 2.2-36.5; P=0.002).

Gastric bypass surgery significantly reduces the prevalence of T2DM. Peripheral fat distribution (smaller waist circumference) and absence of insulin treatment were independent and significant predictors of complete resolution of the T2DM.

Back to 2005 Program

Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Annual Meeting
Job Board
Make a Pledge
Event Calendar